Predictions
Acadia Pharmaceuticals
Start price
Target price
Perf. (%)
€21.86
12.04.22
12.04.22
-
12.04.23
12.04.23
-23.60%
12.04.23
12.04.23
Mirati Therapeutics Inc.
Start price
Target price
Perf. (%)
€39.40
10.12.22
10.12.22
-
10.12.23
10.12.23
-11.52%
02.04.23
02.04.23
Emergent Biosolutions Inc.
Start price
Target price
Perf. (%)
€7.61
18.03.23
18.03.23
€3.00
18.03.24
18.03.24
23.14%
01.04.23
01.04.23
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€26.35
16.06.22
16.06.22
-
16.06.23
16.06.23
-11.95%
31.03.23
31.03.23
Catalent Inc.
Start price
Target price
Perf. (%)
€66.20
08.03.23
08.03.23
-
08.04.23
08.04.23
-5.63%
20.03.23
20.03.23
Future proof or reliable business model
Novocure Ltd
Start price
Target price
Perf. (%)
€64.20
16.03.22
16.03.22
€68.00
16.03.23
16.03.23
-6.99%
17.03.23
17.03.23
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Teladoc Health Inc
Start price
Target price
Perf. (%)
€36.83
03.05.22
03.05.22
€30.00
03.05.23
03.05.23
-38.60%
11.03.23
11.03.23
Significant cyclical dependencies
ROE lower than 10% per year
high free float
Little known brand
Invitae Corp
Start price
Target price
Perf. (%)
€2.86
12.07.22
12.07.22
€2.10
12.07.23
12.07.23
-54.35%
11.03.23
11.03.23
Could be worthwhile Investment >10% per year
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
Nektar Therapeutics
Start price
Target price
Perf. (%)
€2.02
23.01.23
23.01.23
-
23.01.24
23.01.24
-28.00%
03.03.23
03.03.23
Risky Investment
Invitae Corp
Start price
Target price
Perf. (%)
€2.14
16.10.22
16.10.22
-
16.10.23
16.10.23
-3.57%
18.02.23
18.02.23
Risky Investment
Tandem Diabetes Care Inc
Start price
Target price
Perf. (%)
€55.88
16.10.22
16.10.22
-
16.10.23
16.10.23
-27.47%
05.02.23
05.02.23